MALVERN, Pa., April 10, 2019 /PRNewswire/ -- Realm Therapeutics
plc (NASDAQ: RLM) today announces that its 2018 Annual Report is
now available on the Company's website, www.realmtx.com, and will
be posted to those shareholders who have not elected to receive the
document electronically. Today the Company will also file
Form 20-F with the U.S. Securities and Exchange Commission.
2018 Passive Foreign Investment Company (PFIC) Annual
Information Statement
Realm's 2018 PFIC Annual Information
Statement is posted to the Investor Relations section of the
Company's website, www.realmtx.com under the Investor Resources
tab. U.S. shareholders are advised to consult with their tax
advisors with respect to the 2018 PFIC Annual Information
Statement.
About Realm Therapeutics
Realm
Therapeutics is currently exploring strategic alternatives.
The Investing Policy, which remains the strategic focus of the
Directors, requires the Company to seek to invest in, partner with,
acquire and/or be acquired by a company with meaningful development
potential in the life sciences sector or with good overall business
prospects. For more information on Realm Therapeutics, please
visit www.realmtx.com.
Forward Looking Statements
Certain statements contained herein constitute
forward-looking statements. These forward-looking statements
reflect the Company's judgment at the date of this announcement and
are not intended to give any assurance as to future results. Except
as required by Nasdaq or applicable law, the Company expressly
disclaims any obligation or undertaking to release publicly any
updates or revisions to any forward-looking statements contained in
this announcement to reflect any changes in the Company's
expectations about them or any changes in events, conditions or
circumstances on which any such statement is based.
G-RLM
|
Contacts:
Realm Therapeutics plc
Alex Martin, Chief Executive Officer
Marella Thorell, Chief Financial Officer and Chief Operating
Officer
Outside US: +44 (0) 20 3727 1000
US: +1 212 600 1902
|
|
|
|
Argot
Partners
|
FTI
Consulting
|
|
Stephanie
Marks/Claudia
Styslinger
|
Simon
Conway
|
|
+1 212 600
1902
|
+44 (0) 20 3727
1000
|
View original
content:http://www.prnewswire.com/news-releases/realm-therapeutics-announces-2018-annual-report-available-and-form-20-f-filing-300829624.html
SOURCE Realm Therapeutics